Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Reexamination Certificate
2007-11-06
2007-11-06
Lilling, Herbert J. (Department: 1657)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
C424S725000
Reexamination Certificate
active
10759177
ABSTRACT:
Pharmaceutical compositions containing plant essential oils, natural or synthetic, or mixtures or derivatives thereof, for the prevention and treatment of soft tissue cancer in mammals.
REFERENCES:
patent: 4261989 (1981-04-01), Sasaki et al.
patent: 5322844 (1994-06-01), Aranda et al.
patent: 5387584 (1995-02-01), Schnur
patent: 5595756 (1997-01-01), Bally et al.
patent: 5602184 (1997-02-01), Myers et al.
patent: 5605930 (1997-02-01), Samid
patent: 5626854 (1997-05-01), Ichii et al.
patent: 5795910 (1998-08-01), Giese et al.
patent: 5830887 (1998-11-01), Kelly
patent: 5843994 (1998-12-01), Samid
patent: 5911995 (1999-06-01), Uckun
patent: 6028061 (2000-02-01), Bernfield et al.
patent: 6133312 (2000-10-01), Elson
patent: 6147107 (2000-11-01), Dent et al.
patent: 6268163 (2001-07-01), Kongsbak et al.
patent: 6812258 (2004-11-01), Bessette et al.
patent: 0 448 029 (1991-03-01), None
patent: 2 706 771 (1994-12-01), None
patent: 2 151 924 (1985-07-01), None
patent: 93/09770 (1993-05-01), None
patent: WO98/48790 (1998-11-01), None
Reese, J., et al., “Differential DNA-Binding Abilities of Estrogen Receptor Occupied With Two Classes of Antiestrogens: Studies Using Human Estrogen Receptor Overexpressed in Mammalian Cells”,Nucleic Acids Res., 19(23):6595-6602 (1991).
Soto, A. M. et al., “The Role of Estrogens on the Proliferation of Human Breast Tumor Cells (MCF-7)”,J. Steroid Biochem., 23(1):87-94 (1985).
Sukumaran et al., “Inhibition of Tumour Promotion in Mice by Eugenol”,Indian J. Physiol. Pharmacol., 38(4):306-308 (1994).
Wolff, M. et al., “Blood Levels of Organochlorine Residues and Risk of Breast Cancer”,J. Natl. Cancer Inst., 85(8):648-652 (1993).
Yokota, H. et al., “Suppressed Mutagenicity of Benzo[α]pyrene by the Liver S9 Fraction and Microsomes from Eugenol-Treated Rats”,Mutation Research, 172:231-236 (1986).
Computer Caplus Abstract, Oita et al., 1985:427328, “Opthalmic Pharmaceutical”, RO 84026 (1982).
Computer Caplus Abstract, German, 3829200, “Eugenol-Isoeugenol Mixtures for Treatment of AIDS” (1988).
Computer Caplus Abstract, Luc et al., 1993: 168134, “Bacterial Pharmaceutical Composition Containing Chlorhexidine and Eugenol” (1993).
Azuine, M.A. et al., “Chemopreventive efficacy of betal leaf extract and its constituents on 7,12-dimethylbenz(a)anthracene induced carcinogenesis and their effect on drug detoxification sustem in mouse skin”,Indian Journal of Experimental Biology, 29(4):346-351 (1991).
Baker, P.R. et al., “Cell signaling and basement membrane degradation by breast cancer cells”,British Journal of Cancer, 69(Suppl. 21): 18 (1994).
Kinoshita, E. et al., “Activation of MAP kinase cascade induced by human pancreatic phospholipase A2in a human pancreatic cancer cell line”,FEBS Letters, 407(3):343-346 (1997).
Nayfield, S.G., “Tamoxifen's role in chemoprevention of breast cancer: an update”,Journal of Cellular Biochemistry, Suppl. 22:42-50 (1995).
Strobl, J.S. et al., “Mitogenic signal transduction in human breast cancer cells”,General Pharmacology, 26(8):1643-1649 (1995).
Tzanakakis, G.N. et al., “Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole”,Cancer, 65(3):446-451 (1990).
Yokota, H. et al., “Enhancement of UDP-glucuronyltransferase, UDP-glucose dehydrogenase, and glutathione S-transferase activities in rat liver by dietary administration of eugenol”,Biochemical Pharmacology, 37(5):799-802 (1988).
Al-Harbi, M.M. et al., “Influence of anethole treatment on the tumor induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice.”,Eur. J. Cancer Prev., 4(4):307-318 (1995) ABSTRACT.
Basu, A., “The potential of protein kinase C as a target for anticancer treatment.”,Pharmacol. Ther., 59(3):257-280 (1993) ABSTRACT.
Caponigro, F., et al., “Protein kinase C: a worthwhile target for anticancer drugs?”,Anticancer Drugs, 8(1):26-33 (1997) ABSTRACT.
Chang, C.J., et al., “Oncogene signal transduction inhibitors from medicinal plants.”, In Vivo, 10(2):185-190 (1996) ABSTRACT.
Cole K., et al., “Calcium-mediated signal transduction: biology, biochemistry, and therapy.”,Cancer Metastasis Rev., 13(1):31-44 (1994) ABSTRACT.
Crowell, P.L., et al., “Chemoprevention and therapy of cancer by d-limonene.”,Crit. Rev. Oncog., 5(1):1-22 (1994) ABSTRACT.
Crowell, P.L., et al., “Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer.”,Adv. Exp. Med. Biol., 401:131-136 (1996) ABSTRACT.
Crowell, P.L., et al., “Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation.”,Biochem. Pharmacol., 47(8):1405-1415 (1994) ABSTRACT.
Gorelick, N.J., “Genotoxicity of trans-anethole in vitro.”,Mutat. Res., 326(2):199-209 (1995) ABSTRACT.
Gould, M.N., “Cancer chemoprevention and therapy by monoterpenes.”,Environ. Health Perspect., 105(Suppl. 4):977-979 (1997) ABSTRACT.
Glazer, R.I., “The protein kinase ABC's of signal transduction as targets for drug development.”,Curr. Pharm. Des., 4(3):277-290 (1998) ABSTRACT.
Grunicke, H. H., et al., “Protein kinase C modulation.”,Semin. Cancer Biol., 3(6):351-360 (1992) ABSTRACT.
He, L. et al., “Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo.”,J. Nutr., 127(5):668-674 (1997) ABSTRACT.
Hohl, R.J., “Monoterpenes as regulators of malignant cell proliferation.”,Adv. Exp. Med. Biol., 401:137-146 (1996) ABSTRACT.
Levitzki, A., “Targeting signal transduction for disease therapy.”,Curr. Opin. Cell. Biol., 8(2):239-244 (1996) ABSTRACT.
Madukar, B. V., et al., “The causes of cancer: implications for prevention and treatment.”,Indian J. Pediatr., 64(2):131-141 (1997) ABSTRACT.
Mihajlovic, V., et al., “Expression of a mutant regulatory subunit of cAMP-dependent protein kinase in the Caco-2 human colonic carcinoma cell line.”,Biochem. Cell Biol., 70(10-11):1039-46 (1992) ABSTRACT.
Newberne, P.M., et al., “Histopathological evaluation of proliferative liver lesions in rats fed trans-anethole in chronic studies.”,Food Chem. Toxicol., 27(1)21-26 (1989) ABSTRACT.
Palayoor, S. T., et al., “Inhibition of protein kinase C by antieoplastic agents: implications for drug resistance.”,Biochem. Biophys. Res. Commun., 148(2):718-725 (1987) ABSTRACT.
Pawson, T., “Tyrosine kinase signalling pathways.”,Princess Takamatsu Symp., 24:303-322 (1994) ABSTRACT.
Powis, G., “Anticancer drugs acting against signaling pathways.”,Curr. Opin. Oncol., 7(6):554-559 (1995) ABSTRACT.
Powis, G., “Recent advances in the development of anticancer drugs that act against signalling pathways.”,Tumori., 80(2):69-87 (1994) ABSTRACT.
Powis, G., et al., “Inhibiting intracellular signalling as a strategy for cancer chemoprevention.”,Eur. J. Cancer, 30A(8):1138-1144 (1994) ABSTRACT.
Rompelberg, C.L., et al., “Effect of eugenol on the genotoxicity of established mutagens in the liver.”,Food Chem. Toxicol., 34(1):33-42 (1996) ABSTRACT.
Seedorf, K., “Intracellular signaling by growth factors.”,Metabolism, 44(10 Suppl. 4):24-32 (1995) ABSTRACT.
Truhaut, R., et al., “Chronic toxicity/carcinogenicity study of trans-anethole in rats.”,Food Chem. Toxicol., 27(1):11-20 (1989) ABSTRACT.
Uehara, Y., “Protein kinase inhibitor-screening new molecular target therapeutics.”,Gan To Kagaku Ryoho, (Article in Japanese), 24(2):136-144 (1997) ENGLISH ABSTRACT.
Umezawa, K., “Isolation and biological activities of signal transduction inhibitors from microorganisms and plants.”,Adv. Enzyme Regul., 35:43-53 (1995) ABSTRACT.
Weins
Bessette Steven M.
Enan Essam E.
Ecosmart Technologies, Inc.
Lilling Herbert J.
Nixon & Vanderhye P.C.
LandOfFree
Cancer treatment composition and method using natural plant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer treatment composition and method using natural plant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer treatment composition and method using natural plant... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3884994